
TY  - JOUR
TI  - Oral abstracts
JO  - Journal of Diabetes Investigation
JA  - J Diabetes Investig
VL  - 9
IS  - S1
SN  - 2040-1116
UR  - https://doi.org/10.1111/jdi.12938
DO  - doi:10.1111/jdi.12938
SP  - 19
EP  - 46
PY  - 2018
ER  - 

TY  - JOUR
TI  - Clinical care and other categories posters
JO  - Diabetic Medicine
VL  - 28
IS  - s1
SN  - 0742-3071
UR  - https://doi.org/10.1111/j.1464-5491.2011.03233_2.x
DO  - doi:10.1111/j.1464-5491.2011.03233_2.x
SP  - 83
EP  - 203
PY  - 2011
ER  - 

TY  - JOUR
AU  - Bialer, Meir
AU  - Johannessen, Svein I.
AU  - Levy, René H.
AU  - Perucca, Emilio
AU  - Tomson, Torbjörn
AU  - White, H. Steve
TI  - Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII)
JO  - Epilepsia
JA  - Epilepsia
VL  - 58
IS  - 2
SN  - 0013-9580
UR  - https://doi.org/10.1111/epi.13634
DO  - doi:10.1111/epi.13634
SP  - 181
EP  - 221
KW  - Antiepileptic drugs
KW  - Drug development
KW  - Epilepsy
KW  - Epilepsy targets
PY  - 2017
AB  - Summary The Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII) took place in Madrid, Spain, on June 26?29, 2016, and was attended by >200 delegates from 31 countries. The present Progress Report provides an update on experimental and clinical results for drugs presented at the Conference. Compounds for which summary data are presented include an AED approved in 2016 (brivaracetam), 12 drugs in phase I?III clinical development (adenosine, allopregnanolone, bumetanide, cannabidiol, cannabidivarin, 2-deoxy-d-glucose, everolimus, fenfluramine, huperzine A, minocycline, SAGE-217, and valnoctamide) and 6 compounds or classes of compounds for which only preclinical data are available (bumetanide derivatives, sec-butylpropylacetamide, FV-082, 1OP-2198, NAX 810-2, and SAGE-689). Overall, the results presented at the Conference show that considerable efforts are ongoing into discovery and development of AEDs with potentially improved therapeutic profiles compared with existing agents. Many of the drugs discussed in this report show innovative mechanisms of action and many have shown promising results in patients with pharmacoresistant epilepsies, including previously neglected rare and severe epilepsy syndromes.
ER  - 

TY  - JOUR
TI  - Static Poster Abstracts
JO  - Nephrology
JA  - Nephrology
VL  - 21
IS  - S2
SN  - 1320-5358
UR  - https://doi.org/10.1111/nep.12888
DO  - doi:10.1111/nep.12888
SP  - 150
EP  - 280
PY  - 2016
ER  - 

TY  - JOUR
TI  - Posters (Abstracts 264–2239)
JO  - Hepatology
JA  - Hepatology
VL  - 66
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.29501
DO  - doi:10.1002/hep.29501
SP  - 149
EP  - 1185
PY  - 2017
ER  - 

TY  - JOUR
TI  - WORLD TRANSPLANT CONGRESS 2006 POSTER ABSTRACTS
JO  - American Journal of Transplantation
VL  - 6
IS  - s2
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2006.01447.x
DO  - doi:10.1111/j.1600-6143.2006.01447.x
SP  - 473
EP  - 1061
PY  - 2006
ER  - 

TY  - JOUR
TI  - Posters A51
JO  - Clinical and Experimental Pharmacology and Physiology
VL  - 31
IS  - s1
SN  - 0305-1870
UR  - https://doi.org/10.1111/j.1440-1681.2004.cep_4027.pdf.x
DO  - doi:10.1111/j.1440-1681.2004.cep_4027.pdf.x
SP  - A51
EP  - A202
PY  - 2004
ER  - 

TY  - JOUR
TI  - Poster Session I Abstracts
JO  - Peptide Science
JA  - Biopolymers
VL  - 92
IS  - 4
SN  - 0006-3525
UR  - https://doi.org/10.1002/bip.21224
DO  - doi:10.1002/bip.21224
SP  - 334
EP  - 376
PY  - 2009
ER  - 

TY  - JOUR
TI  - PUBLICATION
JO  - Hematological Oncology
JA  - Hematol Oncol
VL  - 31
IS  - S1
SN  - 0278-0232
UR  - https://doi.org/10.1002/hon.2059
DO  - doi:10.1002/hon.2059
SP  - 201
EP  - 270
PY  - 2013
ER  - 

TY  - JOUR
TI  - Poster Presentation
JO  - Journal of Arrhythmia
JA  - Journal of Arrhythmia
VL  - 29
IS  - 5S
SN  - 1880-4276
UR  - https://doi.org/10.1016/S1880-4276(13)60004-6
DO  - doi:10.1016/S1880-4276(13)60004-6
SP  - xvi
EP  - xlviii
PY  - 2013
ER  - 

TY  - JOUR
TI  - Focused Workshops
JO  - European Journal of Neurology
JA  - Eur J Neurol
VL  - 25
IS  - S2
SN  - 1351-5101
UR  - https://doi.org/10.1111/ene.13702
DO  - doi:10.1111/ene.13702
SP  - 629
EP  - 654
PY  - 2018
ER  - 

TY  - JOUR
TI  - Clinical care and other categories posters: audit
JO  - Diabetic Medicine
JA  - Diabet. Med.
VL  - 30
IS  - s1
SN  - 0742-3071
UR  - https://doi.org/10.1111/dme.12091_2
DO  - doi:10.1111/dme.12091_2
SP  - 79
EP  - 201
PY  - 2013
ER  - 

C7  - pp. 1191-1218
TI  - Index
SN  - 9781405159258
UR  - https://doi.org/10.1002/9781444309768.index
DO  - doi:10.1002/9781444309768.index
SP  - 1191-1218
PY  - 2013
ER  - 

TY  - JOUR
TI  - Invited Speakers
JO  - European Journal of Clinical Investigation
JA  - Eur J Clin Invest
VL  - 48
IS  - S1
SN  - 9781405159258
UR  - https://doi.org/10.1111/eci.12924
DO  - doi:10.1111/eci.12924
SP  - 15
EP  - 43
PY  - 2018
ER  - 
